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PreviewsOpen Sesame!
Coxsackieviruses Conspire to
Trespass the Tight Junctional Gate
In the January 13 issue of Cell, Coyne and Bergelson
describe an ‘‘Open sesame!’’ strategy developed by
coxsackieviruses to invade the organism through the
intestinal epithelium. The strategy involves coopting
intrinsic signaling abilities of the apical GPI-anchored
protein DAF to open the tight junction barrier, gain ac-
cess to the primary receptor CAR, and activate virus in-
ternalization by a caveolin-dependent pathway.
Pathogens intent on invading an organism must over-
come imposing epithelial barriers, i.e., thick cornified
skin on the outside and the tightly sealed single epithe-
lial layers of digestive and respiratory mucosae on the
inside. In a recent issue of Cell, Coyne and Bergelson
(2006) present a wonderfully detailed picture of a cun-
ning strategy developed by a subgroup of coxsackievi-
ruses B (CVB) to penetrate intestinal epithelia. Like in
‘‘Ali Baba and the Forty Thieves,’’ the viruses utilize a
magic ‘‘sesame’’ key to open the tight junctional gate
and gain access to the cellular treasures that allow their
replication. This magic key is decay-accelerating factor
(DAF), an apical GPI-anchored protein that, presumably
because of its critical function regulating the deposition
and activation of complement on the cell surface, its
high relative mobility in the plane of the membrane, and
obligate expression on the apical surface of polarized
epithelial cells, has repeatedly been a target for picor-
navirus adhesion. Bergelson’s group had previously
shown that coxsackieviruses display Darwinian skills
in how they develop variants able to bind DAF after
growth in cells that express DAF (Milstone et al., 2005).
The role of DAF in virus entry is far from passive (Fig-
ure 1). DAF is targeted to its normal location at the apical
surface of intestinal cells by its GPI-anchor and the lipid
rafts associated with it (Rodriguez-Boulan et al., 2005).
Although DAF is a GPI-anchored protein, it has been
shown to interact with a variety of proteins on nucleated
cells including tyrosine kinases. The manner in which
DAF interacts with these kinases is not clear (Nichol-
son-Weller and Wang, 1994). The authors convincingly
show that DAF and raft clustering by CVB or by anti-
bodies specifically activates two cellular signals: the
nonreceptor tyrosine kinase Abl and Src family kinases,
including Fyn. Activated Abl is known to mediate actin
remodeling, apparently through Rac activation in the
case of DAF stimulation by CVB (as shown by the au-
thors). The purpose of actin remodeling is to generate
a mechanism to transport the virus to its primary recep-
tor, CAR (coxsackie-adenovirus receptor), an integral
transmembrane protein of the immunoglobulin family,
which is a structural component of TJ (Cohen et al.,
2001). Arrival of CVB promotes junctional disassembly,
reflected in decreased transmonolayer electrical resis-
tance, apparently by mechanical interference of the vi-rus with CAR homophilic adhesion rather than through
effects downstream of DAF activation, such as dis-
ruption of the actin cytoskeleton—a strategy used by
enteropathogenic E. coli (Vogelmann et al., 2004). The
sophisticated strategy used by CVB viruses to open
TJ resembles the use of adenovirus fibers by adenovi-
ruses to dissociate CAR (Walters et al., 2002), although
in the latter case the viruses may depend on junction
opening by epithelial injury or inflammation for the initial
access to CAR.
Coyne and Bergelson show that the binding of CVB
particles to CAR at the TJ is required for capsid desta-
bilization (Figure 1, shown as a change in the color of
CVB particles at the TJ), a step important in the repro-
duction of adenoviruses, reoviruses, and picornavi-
ruses, as it exposes binding sites in the viruses for sec-
ondary receptors and it allows the release of the viral
genetic material from endosomes. Secondary receptors
have been identified for some viral families—for exam-
ple, the avb3/ avb5 integrins used by some adenovi-
ruses—but much remains unknown about the capsid
destabilization step. Coyne and Bergelson confirm
that DAF activation does not promote capsid destabili-
zation (Milstone et al., 2005), which continues to be
a function of the interaction with the primary receptor
CAR, and additionally show that capsid destabilization,
which takes place prior to internalization, is not suffi-
cient for virus endocytosis. The study does add DAF
to the group of coreceptors, which also includes CD46
for other coxsackievirus subfamilies.
Interaction of CVB with CAR leads somehow to inter-
nalization apparently through a caveolin-1 pathway, as
demonstrated by interference with a dominant-negative
caveolin mutant. The activation of caveolin-1 for inter-
nalization appears to be a downstream effect of DAF
clustering. The Src family kinase Fyn is phosphorylated
on Tyr418 10 min after virus binding to DAF, and specific
inactivation of Fyn with pharmacologic and RNAi ap-
proaches inhibited CVB entry. Fyn phosphorylates
caveolin-1 at Tyr14; P-caveolin can then be detected
by immunofluorescence in vesicles containing CVB at
the level of the TJ. Caveolae have been recently shown
to play a key role in virus- and toxin-induced internaliza-
tion of SV40 and cholera toxin in nonpolarized cells
(Pelkmans and Helenius, 2003), but little is known about
the role of caveolae in virus internalization in polarized
cells. Although caveolin-1 may be found at the apical
surface of epithelial cells, typical morphological caveo-
lae are only basolateral in most epithelial cells; to our
knowledge, caveolae have not yet been described at
the level of tight junctions (Rodriguez-Boulan et al.,
2005). The nature of the endocytic vesicles that internal-
ize CVB and caveolin was addressed but not fully solved
by the authors. Inhibitors of clathrin-mediated endocy-
tosis and dynamin did not prevent viral internalization.
As dynamin is involved in the internalization of both
clathrin-coated vesicles and caveolae, the CVB inter-
nalization route may be a novel one, perhaps related
to the clathrin-independent carriers (CLIC), which use
utilize a clathrin- and dynamin-independent mechanism
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2005). However, this mechanism was described for
GPI-anchored proteins and involves cdc42; CVB vesi-
cles exclude DAF and do not seem to require cdc42.
Electron microscopy studies will be helpful to clarify
the morphological features of the endocytic vesicle
that internalizes CVBs. Very little is known about later
stages of the internalization route of CVB, which ap-
pears to include an ER step, although recent evidence
suggests that caveolin-1 might be a determinant of
this route (Pelkmans and Helenius, 2003).
This exciting and very well documented paper high-
lights the extremely dynamic properties of intercellular
junctions, believed just a decade ago to be simple pas-
sive restraining devices. The CVB mechanism is remi-
niscent of strategies that leukocytes use to cross endo-
thelial cell adherens junctions at sites of inflammation.
Leukocyte a4b1 integrins cluster VCAM-1 molecules
Figure 1. Coxackievirus B with Affinity for Decay-Accelerating Fac-
tor Clusters Several DAF Molecules at the Apical Membrane of the
Intestinal Cell, Thus Converting the Associated Small Lipid Rafts
into Larger Functional Rafts
This clustering process activates downstream tyrosine kinase Abl,
which remodels actin via Rac, necessary for driving decay-acceler-
ating factor (DAF) bound coxackievirus B (CVB) to the tight junc-
tions. Here, the viruses are transferred from DAF to their primary
receptor, CAR; this dissociates CAR’s homotypic interactions with
CAR in the neighboring cell. Binding to CAR leads to changes in cap-
sid conformation (dark to light green). DAF clustering also activates
the Src tyrosine kinase Fyn, which phosphorylates and activates
caveolin-1, which promotes virus internalization into vesicles (cav-
eolae?) that exclude CAR and DAF. An hour and a half post infection,
viral particles localize to a perinuclear region rich in ER.on the apical endothelial surface, leading to Rac-1 acti-
vation and loosening of the junctions, possibly via
phosphorylation of vascular endothelial cell-specific
cadherin (VE-cadherin), a process that should facilitate
leukocyte transmigration (Wittchen et al., 2005). At the
endothelial junction, homophilic engagement of leuko-
cyte and endothelial PECAM disrupts homophilic
PECAM-PECAM interactions between endothelial cells
(analogous to CAR-CAR interactions between epithelial
cells) and triggers the recruitment of membrane vesicles
from an intracellular perijunctional depot that surround
the leukocyte with PECAM-bearing membrane and
guide it across the junction (Mamdouh et al., 2003), rem-
iniscent of internalization of CVB into a membrane
bound compartment at the junction. The study by
Coyne and Bergelson provides a beautiful example of
the well-demonstrated usefulness of viruses to eluci-
date important cell biological processes. It has impor-
tant implications for epithelial polarity studies, as the
route followed by CVB through the tight junction might
also be used by cellular proteins attempting to cross
the tight junction barrier during transcytosis.
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